---
title: "LIFERIVER: Plans to repurchase shares for 60 million to 120 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261414825.md"
description: "LIFERIVER announced that the company plans to repurchase a portion of its issued ordinary shares through centralized bidding, with the repurchase amount not less than 60 million yuan and not exceeding 120 million yuan. The funding sources will be from its own funds and special loans for stock repurchase. The repurchase price will not exceed 37.99 yuan per share, and the repurchased shares are intended for the employee stock ownership plan or equity incentives"
datetime: "2025-10-16T10:11:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261414825.md)
  - [en](https://longbridge.com/en/news/261414825.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261414825.md)
generator: "portal-rs"
---

# LIFERIVER: Plans to repurchase shares for 60 million to 120 million yuan

LIFERIVER announced that the company plans to repurchase a portion of its issued ordinary shares through centralized bidding, with the repurchase amount not less than 60 million yuan and not exceeding 120 million yuan. The funding sources will be from its own funds and special loan funds for stock repurchase. The repurchase price will not exceed 37.99 yuan per share, and the repurchased shares are intended for the employee stock ownership plan or equity incentives

### Related Stocks

- [688317.CN](https://longbridge.com/en/quote/688317.CN.md)

## Related News & Research

- [19:16 ETAG.AL Crowned Esports World Cup 2026 Club Champion After Landmark Competition in Paris](https://longbridge.com/en/news/296712807.md)
- [WRT World Agricultural Supply and Demand August 24](https://longbridge.com/en/news/296799679.md)
- [UNM and ScienceSoft Launch First Statewide WHO Healthy Aging Initiative in US](https://longbridge.com/en/news/296641162.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)
- [CanSino Biologics says China NMPA approves adsorbed tetanus vaccine NDA](https://longbridge.com/en/news/296476562.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**